Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesotherapy with piroxicam + lidocaine vs intradermal dry needling for lateral epicondylitis
2021-006462-20Phase 2Active
- Sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of piroxicam and lidocaine in Lateral Epicondylitis (LET) (2 arms), sponsored by Instituto de Medicina Molecular João Lobo Antunes. Primary endpoint: Primary endpoint: change in pain intensity (VAS 0-100). Started Jul 2022; status: active.
02
Drugs
piroxicamlidocaine
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2021-006462-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006462-20.